• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌骨转移:分子与细胞机制(综述)

Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).

作者信息

Ye Lin, Kynaston Howard G, Jiang Wen G

机构信息

Metastasis and Angiogenesis Research Group, University Department of Surgery, Wales College of Medicine, Cardiff University, Cardiff, UK.

出版信息

Int J Mol Med. 2007 Jul;20(1):103-11.

PMID:17549396
Abstract

Prostate cancer is the most common cancer in men in Western countries, with a high incidence of bone metastasis. The bony metastasis is incurable and contributes significantly to disease-specific morbidity and mortality. The molecular and cellular mechanisms leading to the development of bone metastasis in prostate cancer remain unclear, but are currently under intensive investigation. In this review, we summarized the current understanding of bone metastasis in prostate cancer. The rapid progress in the genetic predisposition that makes prostate cancer cells more prone to spread to bone, bone-derived factors which are involved in the development of bone metastasis at the level of the local microenvironment, the interactions between metastatic prostate cancer cells and bone marrow endothelial cells, osteoblasts, and osteoclasts, are discussed in this article.

摘要

前列腺癌是西方国家男性中最常见的癌症,骨转移发生率很高。骨转移无法治愈,且在很大程度上导致了疾病特异性的发病和死亡。导致前列腺癌骨转移发生的分子和细胞机制仍不清楚,但目前正在深入研究。在本综述中,我们总结了目前对前列腺癌骨转移的认识。本文讨论了使前列腺癌细胞更易扩散至骨的遗传易感性方面的快速进展、在局部微环境水平参与骨转移发生的骨源性因子、转移性前列腺癌细胞与骨髓内皮细胞、成骨细胞和破骨细胞之间的相互作用。

相似文献

1
Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).前列腺癌骨转移:分子与细胞机制(综述)
Int J Mol Med. 2007 Jul;20(1):103-11.
2
Mechanisms of tumor metastasis to the bone: challenges and opportunities.肿瘤骨转移的机制:挑战与机遇
J Bone Miner Res. 2003 Feb;18(2):190-4. doi: 10.1359/jbmr.2003.18.2.190.
3
Pathogenesis of osteoblastic bone metastases from prostate cancer.前列腺癌成骨性骨转移的发病机制。
Cancer. 2010 Mar 15;116(6):1406-18. doi: 10.1002/cncr.24896.
4
Current trials using bone-targeting agents in prostate cancer.目前在前列腺癌中使用骨靶向药物的试验。
Cancer J. 2008 Jan-Feb;14(1):35-9. doi: 10.1097/PPO.0b013e318161d32d.
5
A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.基于对肿瘤细胞与微环境相互作用的理解而形成的前列腺癌骨转移治疗范式。
J Cell Biochem. 2005 Oct 15;96(3):439-46. doi: 10.1002/jcb.20522.
6
Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.前列腺癌骨转移的发病机制与治疗:靶向致死表型
J Clin Oncol. 2005 Nov 10;23(32):8232-41. doi: 10.1200/JCO.2005.03.0841.
7
Mechanisms of cancer metastasis to the bone.癌症转移至骨骼的机制。
Cell Res. 2005 Jan;15(1):57-62. doi: 10.1038/sj.cr.7290266.
8
Bone metastases in prostate cancer: a targeted approach.前列腺癌骨转移:一种靶向治疗方法。
Curr Opin Oncol. 2007 May;19(3):254-8. doi: 10.1097/CCO.0b013e32805e8787.
9
Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.前列腺癌骨转移会促进溶骨和成骨活动。
J Cell Biochem. 2004 Mar 1;91(4):718-29. doi: 10.1002/jcb.10662.
10
Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.将参与骨重塑的因子作为前列腺癌骨转移的治疗策略。
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6285s-6290s. doi: 10.1158/1078-0432.CCR-06-0813.

引用本文的文献

1
Genome-wide long non-coding RNA expression profile and its regulatory role in the ileocecal valve from subsp. -infected cattle.亚种感染牛回盲瓣的全基因组长链非编码RNA表达谱及其调控作用
Front Vet Sci. 2025 Jun 5;12:1601267. doi: 10.3389/fvets.2025.1601267. eCollection 2025.
2
The Recruitment and Immune Suppression Mechanisms of Myeloid-Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer.髓源性抑制细胞的招募与免疫抑制机制及其对骨转移性癌症的影响
Cancer Rep (Hoboken). 2025 Feb;8(2):e70044. doi: 10.1002/cnr2.70044.
3
A case report on the atypical metastatic pathway of prostate cancer to the kidney and stomach.
一例前列腺癌转移至肾脏和胃部的非典型转移途径病例报告。
Urol Case Rep. 2024 Aug 3;56:102816. doi: 10.1016/j.eucr.2024.102816. eCollection 2024 Sep.
4
Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination.携带 CD74-ROS1 融合基因的骨转移肺腺癌细胞与巨噬细胞相互作用促进其播散。
Oncogene. 2024 Jul;43(28):2215-2227. doi: 10.1038/s41388-024-03072-7. Epub 2024 May 27.
5
Prostate Cancer Skeletal Metastasis: A Spontaneous Evolution from Osteolytic to Osteoblastic Morphology without Treatment.前列腺癌骨转移:未经治疗情况下从溶骨性到成骨性形态的自然演变
World J Nucl Med. 2023 Dec 26;22(4):316-320. doi: 10.1055/s-0043-1777697. eCollection 2023 Dec.
6
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.MDA-9/Syntenin 在肿瘤和微环境中定义了前列腺癌骨转移。
Proc Natl Acad Sci U S A. 2023 Nov 7;120(45):e2307094120. doi: 10.1073/pnas.2307094120. Epub 2023 Nov 3.
7
Metabolic control of cancer metastasis: role of amino acids at secondary organ sites.癌症转移的代谢控制:二级器官部位氨基酸的作用。
Oncogene. 2023 Nov;42(47):3447-3456. doi: 10.1038/s41388-023-02868-3. Epub 2023 Oct 18.
8
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer.铁补充剂可增强RSL3诱导的铁死亡,以治疗原发性和预防去势抵抗性前列腺癌。
Cell Death Discov. 2023 Mar 6;9(1):81. doi: 10.1038/s41420-023-01383-4.
9
DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis-Challenges and Critical Points in Implementation into Clinical Routine.DOTA-ZOL:在诊断和缓解骨转移方面有前途的工具——在临床常规中实施的挑战和关键点。
Molecules. 2020 Jun 30;25(13):2988. doi: 10.3390/molecules25132988.
10
Dysregulation of cystathionine γ-lyase promotes prostate cancer progression and metastasis.胱硫醚γ-裂解酶失调促进前列腺癌的进展和转移。
EMBO Rep. 2019 Oct 4;20(10):e45986. doi: 10.15252/embr.201845986. Epub 2019 Aug 29.